Galectin-1 Controls the Proliferation and Migration of Liver Sinusoidal Endothelial Cells and Their Interaction With Hepatocarcinoma Cells

Journal of Cellular Physiology

Volumn 231, Issue 7, 2016, Pages 1522-1533

  Manzi, Malena ^a,b   Bacigalupo, María L ^a,b   Carabias, Pablo ^a,b   Elola, María T ^a,b   Wolfenstein Todel, Carlota ^a,b   Rabinovich, Gabriel A ^c   Espelt, María V ^a,b   Troncoso, María F ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 1; GLYCAN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOMA CELL; CELL ADHESION; CELL CULTURE; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIVER CELL; LIVER CELL CARCINOMA; LIVER SINUSOID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TUMOR MICROENVIRONMENT;

CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GALECTIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MICROENVIRONMENT;

EID: 84962541163     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25244     Document Type: Article

References (51)

1. Bacigalupo ML, Manzi M, Rabinovich GA, Troncoso MF. 2013. Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma. World J Gastroenterol 19:8831-8849.
2. Bacigalupo ML, Manzi M, Espelt MV, Gentilini LD, Compagno D, Laderach DJ, Wolfenstein-Todel C, Rabinovich GA, Troncoso MF. 2015. Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells. J Cell Physiol 230:1298-1309.
3. Bedossa P, Peltier E, Terris B, Franco D, Poynard T. 1995. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 21:760-766.
4. Biron VA, Iglesias MM, Troncoso MF, Besio-Moreno M, Patrignani ZJ, Pignataro OP, Wolfenstein-Todel C. 2006. Galectin-1: Biphasic growth regulation of Leydig tumor cells. Glycobiology 16:810-821.
5. Caja L, Sancho P, Bertran E, Fabregat I. 2011. Dissecting the effect of targeting the epidermal growth factor receptor on TGF-beta-induced-apoptosis in human hepatocellular carcinoma cells. J Hepatol 55:351-358.
6. Carr BI, Hayashi I, Branum EL, Moses HL. 1986. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor. Cancer Res 46:2330-2334.
7. Clausse N, van den Brule F, Waltregny D, Garnier F, Castronovo V. 1999. Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion. Angiogenesis 3:317-325.
8. Cogger VC, Arias IM, Warren A, McMahon AC, Kiss DL, Avery VM, Le Couteur DG. 2008. The response of fenestrations, actin, and caveolin-1 to vascular endothelial growth factor in SK Hep1 cells. Am J Physiol Gastrointest Liver Physiol 295:G137-G145.
9. Croci DO, Salatino M, Rubinstein N, Cerliani JP, Cavallin LE, Leung HJ, Ouyang J, Ilarregui JM, Toscano MA, Domaica CI, Croci MC, Shipp MA, Mesri EA, Albini A, Rabinovich GA. 2012. Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma. J Exp Med 209:1985-2000.
10. Croci DO, Cerliani JP, Dalotto-Moreno T, Mendez-Huergo SP, Mascanfroni ID, Dergan-Dylon S, Toscano MA, Caramelo JJ, Garcia-Vallejo JJ, Ouyang J, Mesri EA, Junttila MR, Bais C, Shipp MA, Salatino M, Rabinovich GA. 2014. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell 156:744-758.
11. Chung EJ, Sung YK, Farooq M, Kim Y, Im S, Tak WY, Hwang YJ, Kim YI, Han HS, Kim JC, Kim MK. 2002. Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray. Mol Cells 14:382-387.
12. D'Haene N, Sauvage S, Maris C, Adanja I, Le Mercier M, Decaestecker C, Baum L, Salmon I. 2013. VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis. PLoS ONE 8:e67029.
13. Daroqui CM, Ilarregui JM, Rubinstein N, Salatino M, Toscano MA, Vazquez P, Bakin A, Puricelli L, Bal de Kier Joffe E, Rabinovich GA. 2007. Regulation of galectin-1 expression by transforming growth factor beta1 in metastatic mammary adenocarcinoma cells: Implications for tumor-immune escape. Cancer Immunol Immunother 56:491-499.
14. Demydenko D, Berest I. 2009. Expression of galectin-1 in malignant tumors. Exp Oncol 31:74-79.
15. Dituri F, Serio G, Filannino D, Mascolo A, Sacco R, Villa E, Giannelli G. 2014. Circulating TGF-beta1-related biomarkers in patients with hepatocellular carcinoma and their association with HCC staging scores. Cancer Lett 353:264-271.
16. Dooley S, ten Dijke P. 2012. TGF-beta in progression of liver disease. Cell Tissue Res 347:245-256.
17. Dzieran J, Fabian J, Feng T, Coulouarn C, Ilkavets I, Kyselova A, Breuhahn K, Dooley S, Meindl-Beinker NM. 2013. Comparative analysis of TGF-beta/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines. PLoS ONE 8:e72252.
18. El-Serag HB. 2012. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264-1273. e1261.
19. Elola MT, Wolfenstein-Todel C, Troncoso MF, Vasta GR, Rabinovich GA. 2007. Galectins: Matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci 64:1679-1700.
20. Espelt MV, Croci DO, Bacigalupo ML, Carabias P, Manzi M, Elola MT, Munoz MC, Dominici FP, Wolfenstein-Todel C, Rabinovich GA, Troncoso MF. 2011. Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growth. Hepatology 53:2097-2106.
21. Fabregat I. 2009. Dysregulation of apoptosis in hepatocellular carcinoma cells. World J Gastroenterol 15:513-520.
22. Heffelfinger SC, Hawkins HH, Barrish J, Taylor L, Darlington GJ. 1992. SK HEP-1: A human cell line of endothelial origin. In Vitro Cell Dev Biol 28A:136-142.
23. Hernandez-Gea V, Toffanin S, Friedman SL, Llovet JM. 2013. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology 144:512-527.
24. Hsieh SH, Ying NW, Wu MH, Chiang WF, Hsu CL, Wong TY, Jin YT, Hong TM, Chen YL. 2008. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 27:3746-3753.
25. Hsu DK, Dowling CA, Jeng KC, Chen JT, Yang RY, Liu FT. 1999. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 81:519-526.
26. Hughes RC. 1999. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1473:172-185.
27. Ito K, Stannard K, Gabutero E, Clark AM, Neo SY, Onturk S, Blanchard H, Ralph SJ. 2012. Galectin-1 as a potent target for cancer therapy: Role in the tumor microenvironment. Cancer Metastasis Rev 31:763-778.
28. Jiang SS, Weng DS, Wang QJ, Pan K, Zhang YJ, Li YQ, Li JJ, Zhao JJ, He J, Lv L, Pan QZ, Xia JC. 2014. Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma. J Transl Med 12:273.
29. Kawai HF, Kaneko S, Honda M, Shirota Y, Kobayashi K. 2001. Alpha-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis. Hepatology 33:676-691.
30. Kondoh N, Hada A, Ryo A, Shuda M, Arai M, Matsubara O, Kimura F, Wakatsuki T, Yamamoto M. 2003. Activation of Galectin-1 gene in human hepatocellular carcinoma involves methylation-sensitive complex formations at the transcriptional upstream and downstream elements. Int J Oncol 23:1575-1583.
31. Lalor PF, Lai WK, Curbishley SM, Shetty S, Adams DH. 2006. Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo. World J Gastroenterol 12:5429-5439.
32. Lim MJ, Ahn J, Yi JY, Kim MH, Son AR, Lee SL, Lim DS, Kim SS, Kang MA, Han Y, Song JY. 2014. Induction of galectin-1 by TGF-beta1 accelerates fibrosis through enhancing nuclear retention of Smad2. Exp Cell Res 326:125-135.
33. Lv ZD, Na D, Ma XY, Zhao C, Zhao WJ, Xu HM. 2011. Human peritoneal mesothelial cell transformation into myofibroblasts in response to TGF-b1 in vitro. Int J Mol Med 27:187-193.
34. Mathieu V, de Lassalle EM, Toelen J, Mohr T, Bellahcene A, Van Goietsenoven G, Verschuere T, Bouzin C, Debyser Z, De Vleeschouwer S, Van Gool S, Poirier F, Castronovo V, Kiss R, Feron O. 2012. Galectin-1 in melanoma biology and related neo-angiogenesis processes. J Invest Dermatol 132:2245-2254.
35. Matsuda Y, Yamagiwa Y, Fukushima K, Ueno Y, Shimosegawa T. 2008. Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma. Hepatol Res 38:1098-1111.
36. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Schulte-Hermann R. 1992. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci USA 89:5408-5412.
37. Okano K, Tsuruta Y, Yamashita T, Takano M, Echida Y, Nitta K. 2010. Suppression of renal fibrosis by galectin-1 in high glucose-treated renal epithelial cells. Exp Cell Res 316:3282-3291.
38. Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hirabayashi J, Chernajovsky Y. 1999. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 190:385-398.
39. Salvo E, Garasa S, Dotor J, Morales X, Pelaez R, Altevogt P, Rouzaut A. 2014. Combined targeting of TGF-beta1 and integrin beta3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer. Mol Cancer 13:112.
40. Seow TK, Liang RC, Leow CK, Chung MC. 2001. Hepatocellular carcinoma: From bedside to proteomics. Proteomics 1:1249-1263.
41. Spano D, Russo R, Di Maso V, Rosso N, Terracciano LM, Roncalli M, Tornillo L, Capasso M, Tiribelli C, Iolascon A. 2010. Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness. Mol Med 16:102-115.
42. Tang D, Zhang J, Yuan Z, Gao J, Wang S, Ye N, Li P, Gao S, Miao Y, Wang D, Jiang K. 2014. Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma. PLoS ONE 9:e90476.
43. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454.
44. Thijssen VL, Barkan B, Shoji H, Aries IM, Mathieu V, Deltour L, Hackeng TM, Kiss R, Kloog Y, Poirier F, Griffioen AW. 2010. Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res 70:6216-6224.
45. Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J, Mayo KH, Poirier F, Griffioen AW. 2006. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci USA 103:15975-15980.
46. Tsai JF, Jeng JE, Chuang LY, Yang ML, Ho MS, Chang WY, Hsieh MY, Lin ZY, Tsai JH. 1997. Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma. Br J Cancer 76:244-250.
47. Watchorn TM, Waddell I, Ross JA. 2002. Proteolysis-inducing factor differentially influences transcriptional regulation in endothelial subtypes. Am J Physiol Endocrinol Metab 282:E763-E769.
48. Wu H, Chen P, Liao R, Li YW, Yi Y, Wang JX, Sun TW, Zhou J, Shi YH, Yang XR, Jin JJ, Cheng YF, Fan J, Qiu SJ. 2012. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection. J Gastroenterol Hepatol 27:1312-1319.
49. Wu MH, Ying NW, Hong TM, Chiang WF, Lin YT, Chen YL. 2014. Galectin-1 induces vascular permeability through the neuropilin-1/vascular endothelial growth factor receptor-1 complex. Angiogenesis 17:839-849.
50. Xu Z, Shen MX, Ma DZ, Wang LY, Zha XL. 2003. TGF-beta1-promoted epithelial-to-mesenchymal transformation and cell adhesion contribute to TGF-beta1-enhanced cell migration in SMMC-7721 cells. Cell Res 13:343-350.
51. Zhang H, Ozaki I, Mizuta T, Yoshimura T, Matsuhashi S, Eguchi Y, Yasutake T, Hisatomi A, Sakai T, Yamamoto K. 2004. Transforming growth factor-beta 1-induced apoptosis is blocked by beta 1-integrin-mediated mitogen-activated protein kinase activation in human hepatoma cells. Cancer Sci 95:878-886.